Psoriasis Study Pre-Screening Questionnaire

We are currently recruiting subjects aged 18 years and older with moderate to severe plaque psoriasis to participate in an investigational study. The primary purpose of this research is to evaluate the safety, tolerability (your immune response) and effectiveness of an oral (taken by mouth) investigational drug called VTX958 in participants with moderate to severe psoriasis.

Compensation may be provided for time and travel - participation in this study will come at no cost to you.

Visits: 8
Study Length: 20 Weeks

Please answer the following questionnaire to the best of your ability. It should take approximately 5 – 7 minutes to complete.

* Questions with a red star are mandatory.

Start Questionnaire